← Leaderboards
Robert T Striker
University Of Wisconsin Madison
$387,957
Attributed
$387,957
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $129.3K · FY2005–21$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$387,957 · 1
VA$0 · 2
By mechanism
K08$387,957 · 1
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Mark R Albertini$1,770,800
- Diane M Puccetti$719,707
- Yousif H Matloub$547,398
Others in their field
Top investigators on “Investments”
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Everette D Joseph · Howard University$243,972,016
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
Research focus
InvestmentsInsightMutantProteinsPathogenVeteransFamilyInhibitor/AntagonistLeadPharmaceutical PreparationsResourcesBaseSmall MoleculeUnited StatesBiochemicalCellsGeneticIndustryRibavirinHepatitis C VirusRepliconSiteAntimycobacterial AgentsAntimicrobial
Grant awards (10)
Novel selective substituted aminofurazans kinase inhibitors for Drug resistant Bacteria$0
I01 · FY2021 · VA · contact PI
Novel selective substituted aminofurazans kinase inhibitors for Drug resistant Bacteria$0
I01 · FY2020 · VA · contact PI
Novel selective substituted aminofurazans kinase inhibitors for Drug resistant Bacteria$0
I01 · FY2019 · VA · contact PI
Novel selective substituted aminofurazans kinase inhibitors for Drug resistant Bacteria$0
I01 · FY2018 · VA · contact PI
Genotyping and Phenotyping the Hepatitis C Drug Target NS5A$0
I01 · FY2011 · VA · contact PI
Genotyping and Phenotyping the Hepatitis C Drug Target NS5A$0
I01 · FY2011 · VA · contact PI
Genotyping and Phenotyping the Hepatitis C Drug Target NS5A$0
I01 · FY2009 · VA · contact PI
Effect of Thiopurines on RNA Viruses/Hepatitis C Virus$129,319
K08 · FY2005 · AI
Effect of Thiopurines on RNA Viruses/Hepatitis C Virus$129,319
K08 · FY2004 · AI
Effect of Thiopurines on RNA Viruses/Hepatitis C Virus$129,319
K08 · FY2003 · AI